논문명
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer.
발표지
Cancer Chemother Pharmacol
발표년월
2010
공동연구자
Oh DY, Cha Y, Choi IS, Yoon SY, Choi IK, Kim JH, Oh SC, Kim CD, Kim JS, Bang YJ, Kim YH.
논문명
Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer.
발표지
J Thorac Oncol
발표년월
2010
공동연구자
Koh Y, Jang B, Han SW, Kim TM, Oh DY, Lee SH, Kang CH, Kim DW, Im SA, Chung DH, Kim YT, Kim TY, Kim YW, Kim JH, Heo DS, Bang YJ
논문명
Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy.
발표지
J Korean Med Sci
발표년월
2010
공동연구자
Kim K, Chie EK, Han W, Noh DY, Park IA, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW
논문명
Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity.
발표지
Jpn J Clin Oncol
발표년월
2010
공동연구자
Lim KH, Oh DY, Chie EK, Han W, Im SA, Kim TY, Park IA, Noh DY, Ha SW, Bang YJ
논문명
Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy.
발표지
Am J Clin Oncol
발표년월
2010
공동연구자
Kim K, Chie EK, Han W, Noh DY, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW
논문명
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
발표지
Jpn J Clin Oncol
발표년월
2009
공동연구자
Kim K, Chie EK, Jang JY, Kim SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.
논문명
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer.
발표지
Br J Cancer
발표년월
2009
공동연구자
Han SW, Oh DY, Im SA, Park SR, Lee KW, Song HS, Lee NS, Lee KH, Choi IS, Lee MH, Kim MA, Kim WH, Bang YJ, Kim TY.
논문명
Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment.
발표지
Ann Oncol
발표년월
2009
공동연구자
Moon HG, Han W, Lee JW, Ko E, Kim EK, Yu JH, Kang SY, Moon WK, Cho N, Park IA, Oh DY, Han SW, Im SA, Noh DY
논문명
The role of PET/CT in detection of gastric cancer recurrence.
발표지
BMC Cancer
발표년월
2009
공동연구자
Sim SH, Kim YJ, Oh DY, Lee SH, Kim DW, Kang WJ, Im SA, Kim TY, Kim WH, Heo DS, Bang YJ.
논문명
Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6.
발표지
Cancer Sci
발표년월
2009
공동연구자
Han SW, Oh DY, Im SA, Park SR, Lee KW, Song HS, Lee NS, Lee KH, Choi IS, Lee MH, Kim MA, Kim WH, Bang YJ, Kim TY.
논문명
Is Duodenal Invasion a Relevant Prognosticator in Patients Undergoing Adjuvant Chemoradiotherapy for Distal Common Bile Duct Cancer?
발표지
Int J Radiat Oncol Biol Phys
발표년월
2009
공동연구자
Kim K, Chie EK, Jang JY, Kim SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW
논문명
Weekly paclitaxel and trastuzumab as a first-line therapy in patients with HER2-overexpressing metastatic breast cancer: magnitude of HER2/neu amplification as a predictive factor for efficacy.
발표지
J Korean Med Sci
발표년월
2009
공동연구자
Han HS, Kim JS, Park JH, Jeon YK, Lee KW, Oh DY, Kim JH, Park SY, Im SA, Kim TY, Park IA, Bang YJ.
논문명
Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer?: a non-randomized, single center study.
발표지
BMC Cancer
발표년월
2009
공동연구자
Lim KH, Oh DY, Chie EK, Jang JY, Im SA, Kim TY, Kim SW, Ha SW, Bang YJ.
논문명
Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells.
발표지
Mol Cancer Ther
발표년월
2009
공동연구자
Yoon YK, Kim HP, Han SW, Hur HS, Oh do Y, Im SA, Bang YJ, Kim TY
논문명
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study.
발표지
Cancer Chemother Pharmacol
발표년월
2009
공동연구자
Lee J, Jung KH, Park YS, Ahn JB, Shin SJ, Im SA, Oh do Y, Shin DB, Kim TW, Lee N, Byun JH, Hong YS, Park JO, Park SH, Lim HY, Kang WK
논문명
Public awareness of gastric cancer risk factors and disease screening in a high risk region: a population-based study.
발표지
Cancer Res Treat
발표년월
2009
공동연구자
Oh DY, Choi KS, Shin HR, Bang YJ
발표지
PLoS One
발표년월
2009
공동연구자
Kim HP, Yoon YK, Kim JW, Han SW, Hur HS, Park J, Lee JH, Oh DY, Im SA, Bang YJ, Kim TY.
논문명
Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma.
발표지
Ann Oncol
발표년월
2009
공동연구자
Lee JO, Lee KW, Oh DY, Kim JH, Im SA, Kim TY, Bang YJ
논문명
Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
발표지
Int J Radiat Oncol Biol Phys
발표년월
2009
공동연구자
Kim K, Chie EK, Jang JY, Kim SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.